Raising Capital Through IP. WIPO-WASME Special Program on Practical IPRs Issues - Geneva, May 3 to 6, 2004

Similar documents
Intellectual property and access to finance for high growth SMEs

SWK Holdings. May 2012

20 Intellectual Property as Securitized Assets

OPC FOUNDATION INTELLECTUAL PROPERTY RIGHTS POLICY VERSION APR 2018

Best Practices on Intellectual Property (IP) Valuation and Financing in APEC

Hong Kong Proposes Changes to Attract Listing of Innovative Companies on the Main Board

Dechert and Life Sciences A GLOBAL MULTI-DISCIPLINARY TEAM. EXPERT LAWYERS. ADVICE THAT ADDS VALUE.

Innovation, Intellectual property and Financing

NTD INTELLECTUAL PROPERTY

A guide to intellectual property and intangible assets

Information Sheet No. 66. The New Intellectual Property (IP) Tax Regime in Cyprus

WIPO LIST OF NEUTRALS BIOGRAPHICAL DATA

IPR-intensive industries: contribution to economic performance and employment in the European Union

Valuing Biotechnology Companies. Neil J. Beaton, CPA/ABV/CFF, CFA, ASA Alvarez & Marsal Valuation Services, LLC October 9, 2017

Application of Policy This policy applies to all PSU employees.

Revenue from contracts with customers The standard is final A comprehensive look at the new revenue model

Tokyo Office. Local Roots OVER FOUR DECADES IN JAPAN. Japanese attorneys. Gaikokuho Jimu Bengoshi. Tax attorneys.

Intellectual property rights in Luxembourg (IPR): tax exemption

EP GLOBAL COMMUNICATIONS, INC Martin Street, Irvine CA

Worcestershire Mental Health Partnership NHS Trust. Intellectual Property & Property Rights Policy.

Immersion Corporation Reports Fourth Quarter and Fiscal 2013 Results

IP Monetization in Climate Technology Transfer Promotion

Intellectual property rights intensive industries: contribution to economic performance and employment in Belgium

IP valuation, exploitation and finance

Exploiting & Protecting IP in Ireland

Half year report for the six months to 31 March An outstanding six months, strengthening our leading position in Life Sciences

Drug Royalty II $701,420,000. Presentation to: San Diego County Employees Retirement Association

Practical Lessons in Using Intellectual Property as Collateral

May 21st, 2013 UNDERSTANDING THE FINANCIAL VALUE OF YOUR PATENT PORTFOLIO: A PRACTICAL GUIDE TO TECHNOLOGISTS AND ENGINEERS

Thailand s SMEs Promotion on Credit Access

Intra-Group Services & Intangibles

University of Florida Professional Speaker Series September 7, 2007

- Definition - Qualitative and Quantitative IP Valuation

Q&A Addressing SEC Proposed New Rule Regulating Funds Use of Derivatives

Life Sciences Accounting and Financial Reporting Update Interpretive Guidance on Consolidation

PHOTON CONTROL INC. Interim Financial Statements (Unaudited) For the nine months ended September 30, 2010

CFTC Proposes First Clearing Mandate and Finalizes Phased Compliance Rules

22nd Century Group, Inc. (XXII - $ Buy)

Data. Insights. Results.

Canadian Intellectual Property Office Submission to Competition Policy Review Panel January 11,2008

Exploiting Intellectual Property Rights: Key Attractions of Locating Operations in Ireland

Potential Advantages of Mediation and Arbitration for Resolving IP and Technology Disputes

VALUATION PROPERTY RIGHTS

FY2006. First Quarter Consolidated Results (Quarter ended June 30, 2006) Sony Corporation Investor Relations

Why invest in Ireland? At a glance

The ICC Launches New Guide for In-House Counsel on Effective Management of International Arbitration

THIRD QUARTER 2018 RESULTS November 6, 2018

U.S. Tax Benefits for Exporting

Software and Software Tools Ownership and Use Contracting Considerations When Creating Digital, Online and Mobile Content

Quarterly Financial Statements for the First Quarter Ended June 30, 2018 And Outlook for the Fiscal Year Ending March 31, 2019

Financial Review. Financial Information and Data. Overview of the Year Ended March 31, 2017 (Fiscal 2016) Sales. Sales by Region

Cyprus Tax News Amendments to Cyprus s IP regime

Q2 13 FINANCIAL HIGHLIGHTS

Jazz Pharmaceuticals and Azur Pharma A Compelling Strategic Combination. Bruce Cozadd, Chairman and CEO

(20 minutes presentation) Intro What is money? Equity, what is it, how does it work, where to find it, how much does it cost? Funding Where to find

Quarterly Financial Statements for the Third Quarter Ended December 31, 2017 And Outlook for the Fiscal Year Ending March 31, 2018

Life Sciences Accounting and Financial Reporting Update Interpretive Guidance on Consolidation

Full Year Results. December Richard Thompson Chief Executive Officer. Andrew Brode Chairman. Desmond Glass Chief Financial Officer

Agenda. South African Tax and Exchange Control Implications of Export of Intellectual Property ( IP )

Intellectual Property

Investors Presentation

Q1 14 FINANCIAL HIGHLIGHTS. April 15, 2014

Pharmaceuticals. IFRS 15 Revenue Are you good to go? kpmg.com/ifrs KPMG IFRG Limited, a UK company limited by guarantee. All rights reserved.

Intellectual Property Protection in China and Valuation of Intellectual Property. Alan J. Cox, Ph.D. NERA San Francisco

Catalent to Acquire Cook Pharmica. September 19, 2017

Brokers. Summary of services/products as provided by the supplier. IP Insurance info: ADF Insurance Brokers Ltd. Website:

Chapter 15. Entry Strategy and Strategic Alliances

October 21, 2011 John Higgins, President and CEO. BioCentury NewsMakers Conference - New York

The Funding Landscape for Small Biopharma Ventures,

How should companies react to the new 10 per cent. tax rate on patent profits?

The Internal Revenue Service (IRS) put forth the investor model in the proposed

ONAP Project A project of The Linux Foundation Software Grant and Corporate Contributor License Agreement ("Agreement") v1.0

Intellectual Property Valuation and Innovation

B. Riley Investor Conference. May 23, 2018

Foreign Investment and IP Protection in China

BRIEFING ON THE SINGLE MARKET STRATEGY Brussels, May 18, 2016

Finding the capital you need to help your private business grow

Considerations in the Valuation of Royalties and Licensing Agreements

TOP 10 LEGAL MISTAKES STARTUPS MAKE

Foreign Direct Investment

Acushnet Holdings Corp.

Form 8-K. OPIANT PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter)

Final Regulations Adopt Most Proposed Regulations

Small-Cap Research. scr.zacks.com 10 S. Riverside Plaza, Chicago, IL OUTLOOK ZACKS ESTIMATES

VENTURE LIFE GROUP PLC. ( Venture Life or the Group ) Unaudited interim results for the six months ended 30 June Momentum continues to build

Acrux (ASX: ACR) Annual General Meeting. 10 November, 2016

PATENT BOX HOW TO REDUCE UK CORPORATION TAX

E145. Workshop B Staged Venture Financing

Global Finance. Asset-backed securities and derivatives

Debt Consulting. Alternative Financing: Term Debt Options for Life Science and Medical Device Companies. Debt. January 1, 2016.

The Volcker Rule: Implication for Private Fund Activities

Selecting Discount Rates in the Application of the Income Method

Technical Line FASB final guidance

PREPARED DIRECT TESTIMONY ON BEHALF OF SAN DIEGO GAS & ELECTRIC COMPANY (DESCRIPTION OF THE UNREGULATED SUBSIDIARY AND ITS INTERACTIONS WITH SDG&E)

THE OECD BEPS ACTION PLAN

Transfer pricing of intangibles

Pharmacy Benefit Strategies for Lowering Prescription Drug Costs

How to value your start-up Dr. Patrik Frei January 2016 San Francisco

GOING GLOBAL EXPORTING TO THE US

For more than 175 years, Baker Botts has been among the leading law firms in the world. Today, with 725 lawyers based in 14 offices around the world,

Transcription:

Raising Capital Through IP WIPO-WASME Special Program on Practical IPRs Issues (Geneva, May 3 to 6, 2004) Federico Guicciardini C. S. Deputy Director SMEs Division of WIPO

Introduction IP assets can be sold, licensed, used as collateral or security for debt finance, can attract private investors (such as business angels, venture capitalists, specialized and even regular banks) IP assets owners can obtain financial support from Governments IP assets can be monetized but only if properly valuated

Topics Why IP Assets Have Value Monetize IP Assets Conclusions

Why IP Assets Have Value Can be legally protected Can create income Can be valued Can attract investors Can boost R&D

Monetize IP Assets Know what IP you own Undertake IP asset valuation Check existing laws Identify potential partnerships Identify the best source of finance

Potential of IP assets as source of finance is a matter of great interest among investors, particularly if supported by reliable and innovative valuation methodologies The IP asset valuation give you: the real value of your IP assets and not the price the estimate of how much capital can the IP assets attract

In using IP assets for financing, special attention has to be devoted to: Whether or not the assets are legally protected Ownership status (absence of litigation proceeding, for instance) Potential of the underlying IP asset to maintain its value (absence of clear challenge to its competitive edge)

Some large corporate and companies have successfully used their IP assets to raise finance While very few SMEs have done so, mainly because of lack of awareness

Areas where IP assets have been used successfully to raise finance include: Licensing IP assets (royalties) Assigning of IP assets

Licensing In most universities, licensing pays for less than 5% of R&D costs. Maximum is 20% at Stanford and Columbia (see Google s example)

New areas where IP assets may be used to raise finance include: Collateral IP asset-backed security Venture capital Business Angels

Collateral Companies can use their IP assets as loan collateral, provided that they are able to prove their liquidity, value, durability and marketable power Importance of obtaining an objective valuation of the identified IP asset Acceptance of IP assets as collateral need to be supported by respective national laws

Examples of use of IP assets as collateral: Michael Jackson was reported to have borrowed US$ 200m from Sony using the Beatles catalogue as collateral GIK Worldwide, a San Francisco based company, used its patents as collateral for raising US$ 17m

Two examples of Government support in using IP assets as collateral: In 2001, Taiwan's Cabinet has revised proposals to give the biotech industry a five-year exemption of tax and allow intellectual property rights (IPRs) of companies to be used as collateral to apply for bank loans. In Spain IP owners may use their IP assets in order to get loans from public banks or private investors

IP asset-backed Taking an intangible asset (such as a patent being licensed to a third party) and utilize the future cash flows from the license payments or royalties to secure current financing for the licensor IP securitization is a growing financial area (so far the value of business done is estimated at US$ 6 billion) Sectors: Pharma, medical, electronics, chemicals, mechanical devices, music, film industry IPRs: Patents, copyrights and trademarks

IP asset-backed main benefits: Immediate liquidity in the form of tax-free cash infusion The IP holder diversify his/her assets The IP holder maintains total control over his/her IP rights which revert to the holder when the bonds are paid (mature)

Example of use of IP as asset-backed: In 1997, David Bowie issued 10-year asset-backed bonds using future royalties on publishing rights and master recording from 25 albums recorded before 1990, raising about US$ 55 million Similarly, James Brown raised US$ 30 million In 1993, Calvin Klein raised US$58 million with the securitization of royalties on perfume brands, arising from the exclusive right to use the Calvin Klein trade mark on existing and future products

Venture capital An investment in a start-up business that is perceived to have excellent growth prospects but does not have access to capital markets An alternative source of fund raising Well managed IP portfolios can influence decisions of venture capital investors

Example of use of IP assets in venture capital: Google s success story Jazz Pharmaceuticals, a Palo Alto-based company, which develops drugs for brain and mental disorders, raised $250 million in March 2004, the most ever for a start-up's second round of funding

Business Angels Family, friends or close associates with money and, in most cases, a business background Expect returns on their investment IP knowledgeable business angels would favorably consider investing in enterprises with IP assets

Conclusions Increase awareness of policy makers and SMEs support institutions on new fund-raising financial strategies leveraging IP assets Increase coordination between IP and specific financial sectors IP rights should not used only for preventing others entering the market

Many thanks for your kind attention